SCHEMBL14058943

SCHEMBL14058943

O=CCc1ccc(OCCCN2CCOCC2)cc1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 8/20 0.67
▸ MAPK1 P28482 2/20 0.67
▸ ALDH1A1 P00352 1/20 0.67
▸ CYP1A2 P05177 1/20 0.67
▸ CHRM2 P08172 1/20 0.67
▸ CHRM1 P11229 1/20 0.67
▸ HTR2A P28223 1/20 0.67
▸ SCN1A P35498 1/20 0.67
▸ HTR2B P41595 1/20 0.67
▸ KCNH2 Q12809 1/20 0.67
▸ SCN2A Q99250 1/20 0.67
▸ SIGMAR1 Q99720 1/20 0.67
▸ SCN3A Q9NY46 1/20 0.67
▸ USP2 O75604 1/20 0.65
▸ LMNA P02545 1/20 0.65
▸ HRH2 P25021 1/20 0.58
▸ HRH1 P35367 1/20 0.58
▸ LTA4H P09960 1/20 0.57
▸ EPHX2 P34913 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5738766 0.93 LTA4H (0.66) HRH3MAPK1ALDH1A1CYP1A2CHRM2
SCHEMBL4730254 0.84 HRH3 (0.68) HRH3MAPK1ALDH1A1CYP1A2CHRM2
SCHEMBL28636689 0.82 HRH3 (0.73) HRH3MAPK1ALDH1A1CYP1A2CHRM2
SCHEMBL13186317 0.82 HRH3 (0.80) HRH3MAPK1ALDH1A1CYP1A2CHRM2
SCHEMBL8795711 0.82 HRH3 (0.70) HRH3MAPK1ALDH1A1CYP1A2CHRM2
SCHEMBL21757567 0.81 HRH3 (0.63) HRH3MAPK1ALDH1A1CYP1A2CHRM2
Pramoxine SCHEMBL26020 0.80 ALDH1A1 (1.00) HRH3MAPK1ALDH1A1CYP1A2CHRM2
SCHEMBL23963137 0.80 HRH3 (0.67) HRH3MAPK1ALDH1A1CYP1A2CHRM2
SCHEMBL21119254 0.80 LTA4H (0.64) HRH3MAPK1ALDH1A1CYP1A2CHRM2
SCHEMBL17296202 0.80 HRH3 (0.62) HRH3MAPK1ALDH1A1CYP1A2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012162461-A1 PHENYL-THIAZOLYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION JANSSEN PHARMACEUTICA NV (BE) 2012-11-29 — — WO disclosed
Send feedback